Skip to main content
Clinical Trials/ACTRN12623000793617
ACTRN12623000793617
Recruiting
未知

Get A Grip: Spinal stimulation for upper limb and respiratory function in incomplete tetraplegia: a Bayesian Optimal Phase II trial

euroscience Research Australia (NeuRA)0 sites48 target enrollmentJuly 24, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Spinal Cord Injury- Incomplete tetraplegia
Sponsor
euroscience Research Australia (NeuRA)
Enrollment
48
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 24, 2023
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
euroscience Research Australia (NeuRA)

Eligibility Criteria

Inclusion Criteria

  • Aged 18 years or older
  • \- Have a motor incomplete (American Spinal Injury Association (ASIA) Impairment Scale (AIS) C or D) spinal cord injury sustained a minimum of 12 months prior to consent.
  • \- Able to breathe independently
  • \- Have an injury level between C2 and C8 neurological levels.
  • \- Willing and able to participate in a training program three times a week for 6 weeks

Exclusion Criteria

  • Have a history of clinically significant autonomic dysreflexia in response to electrical stimulation
  • Unable to elicit reflexes whilst experiencing the stimulation
  • Cannot tolerate spinal stimulation at a therapeutic intensity
  • Have a progressive neurological disease or other major neurological condition other than the spinal cord injury (e.g., severe traumatic brain injury or stroke)
  • Open surgery within the last 3 months
  • Syrinx (fluid\-filled cyst or cavity in spinal cord) on recent MRI
  • Severe upper limb spasticity or contractures
  • Any serious medical condition, cognitive impairment (i.e. trouble remembering or learning), drug dependency, psychiatric illness or behavioural problem preventing you from adhering to the protocol
  • Cardiac pacemaker or pregnant
  • Stem cell or olfactory ensheathing cell therapy within the last 5 years

Outcomes

Primary Outcomes

Not specified

Similar Trials